Carl Icahn's Portfolio
|Ticker||# of Shares||Price||Value|
|View Additional Portfolio Information »|
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Market Wrap: Home Prices Show Strong Gains; Apple Taps Debt Markets; Best Buy Eases Exposure
Stocks Crossing 50-Day SMA 12/10: (HPQ) (MCP) (ACI) Above; (AIG) (SIRI) (SWHC) Below
Pre-Open Movers 4/3: (BNNY) (CVI) (AAPL) Higher; (UEC) (GWRE) (NFLX) Lower (more...)
Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
After-Hours Movers 6/17: LVLT, LGF, SIRI, AZO Higher; IMGN, SOA, HPT, CLC Lower
Unusual 11 Mid-Day Movers 9/10: ACBA, AVAV, STLD, RBN Higher; ENCO, DTG, GFIG, WM Lower
Second Quarter GDP Release Set to Confirm or Deny U.S. Recessionary Fears
Top 10 News Items for the Week of July 21-25: American Express (AXP), Bank of America (BAC), Costco (COST), More...